IP Library Granted Patent US 7,973,018
Granted Patent B2
US 7,973,018 · App. 11/665,416 · Granted Jul 5, 2011

Cell cycle arrest and apoptosis

Assignee: University of Utah Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,973,018
App. No.
11/665,416
Granted
Jul 5, 2011
Kind
B2
Abstract

The HIV-1 accessory gene vpr encodes a conserved 96-amino acid protein that is necessary and sufficient for the HIV-1-induced block of cellular proliferation and induction of apoptosis. Expression of vpr in CD4 + lymphocytes results in G2 arrest, followed by apoptosis. ATR, as a cellular factor that mediates Vpr-induced cell cycle arrest, is required for activation of the Breast Cancer-Associated Protein-1 (BRCA1). In addition, the Growth Arrest and DNA Damage protein (GADD45) is upregulated by Vpr in an ATR-dependent manner. Posttranscriptional silencing of either ATR or GADD45 leads to nearly complete suppression of the pro-apoptotic and/or cell cycle arrest effect of Vpr.

Claims (9)

1. A method of inducing apoptosis in a cancer cell, the method comprising:

introducing HIV-1 Viral protein R (Vpr) and Breast Cancer-Associated Protein I (BRCA1) to a cancer cell; and

inducing apoptosis in the cancer cell; wherein the cancer cell has been identified as lacking a functional BRCA1 gene.

2. The method according to claim 1 , wherein the cancer cell is in a subject.

3. The method according to claim 2 , wherein the subject is a mammal.

4. The method according to claim 1 , wherein the cancer cell comprises a cell culture system.

5. A method of treating a cancer in a subject comprising conducting on the subject the method of claim 2 .

6. The method of claim 5 , wherein the cancer is breast cancer.

7. The method of claim 1 , wherein the Vpr and BRCA1 are expressed by an expression vector.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 13, 2015
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035656/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2008
From: ANDERSON, JOSHUA L; ZIMMERMAN, ERIK; PLANELLES, VICENTE
To: UNIVERSITY OF UTAH
Reel/Frame 021393/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2008
From: UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 021393/0783 →
Continuity (1)
Related Publication 20080300201A1 · Dec 4, 2008